Posted: October 16, 2020

Letter of Intent due 30 days prior to application; Application due December 10, 2020

The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.

See full solicitation here

Office of Grants and Contracts


107 Ag Administration Building
University Park, PA 16802